reports
ASM share buyback update May 15 – 17, 2024
ASM share buyback update May 15 – 17, 2024 Almere, The Netherlands May 21, 2024, 5:45 p.m. CET ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASM's current share buyback program. DateRepurchased sharesAverage priceRepurchased valueMay 15, 20245,161€ 628.21€ 3,242,172May 16, 20244,800€ 651.96€ 3,129,395May 17, 20245,200€ 647.43€ 3,366,635Total15,161€ 642.32€ 9,738,202 These repurchases were made as part of the €150 million share buyback program which started on May 15, 2024. Of the total program, 6.5% has been repurchased. For further de...
- Pierre FerraguÊ
Bible 1Q24 – Semicap: recovery on track, positive 2025 outlook in expe...
Today, we are publishing the Semicap section of our 23rd Tech Infrastructure Quarterly Bible. The Tech Bible is a must-read for any tech investor, as it summarizes the quarterly earnings reports from the over 130 companies we track, providing an update on our key perspectives and convictions. In the coming weeks we will publish sections on Automotive, Cloud Infrastructure, Telecom Equipment, Industrials, PCs, Enterprise IT, and Ride sharing & Delivery. Semicap equipment revenues were in line wi...
BioNTech präsentiert auf der ASCO-Jahrestagung 2024 klinische Daten-Up...
BioNTech präsentiert auf der ASCO-Jahrestagung 2024 klinische Daten-Updates zu innovativen Immuntherapie-Kandidaten MAINZ, Deutschland, 21. Mai 2024 – (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der diesjährigen Jahrestagung der American Society of Clinical Oncology („ASCO“), die vom 31. Mai bis 4. Juni 2024 in Chicago, Illinois, stattfindet, klinische Studiendaten für ausgewählte Programme aus der innovativen Immuno-Onkologie-Pipeline des Unternehmens präsentieren. Darüber hinaus wird BioNTech auch epidemiologische Daten sowie Erkenntnisse aus der Praxis aus zwei Beobachtun...
BioNTech to Present Clinical Data Updates for Next-Generation Immunoth...
BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024 MAINZ, Germany, May 21, 2024 – (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected programs from the Company’s diversified immuno-oncology pipeline at the American Society of Clinical Oncology (“ASCO”) Annual Meeting in Chicago, Illinois, from May 31 to June 4, 2024. Moreover, in support of the Company’s ongoing CAR-T cell and individualized mRNA programs, BioNTech will also present epidemiological and real-world data from two observat...
STMicroelectronics Announces Status of Common Share Repurchase Program
STMicroelectronics Announces Status of Common Share Repurchase Program STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares – Period from May 13, 2024 to May 17, 2024 AMSTERDAM – May 20, 2024 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated July 1, 2021. The Program was approved by a shareholder resolution...
- Research Department
INFORME DIARIO 20 MAYO (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACERINOX, IBERDROLA, TALGO, TELEFÓNICA. EUROPA: ASML. Buena semana para la periferia europea y EE.UU. Semana de avances de hasta el +2,0% en la periferia europea y de nuevos máximos anuales en el S&P 500, beneficiadas por la decepción en los datos macro y el recorte en la rentabilidad de la deuda. Dentro del STOXX 600, lideraron las ganancias semanales los sectores Telecos e Inmobiliario (c. +3,0%) mientras que Energía y Viajes&Ocio terminaron con l...
Aktionärinnen und Aktionäre stimmen auf der ordentlichen Hauptversamml...
Aktionärinnen und Aktionäre stimmen auf der ordentlichen Hauptversammlung 2024 der BioNTech SE allen Tagesordnungspunkten zu MAINZ, Deutschland, 17. Mai 2024 (GLOBE NEWSWIRE) — (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) hat heute, am 17. Mai 2024, die diesjährige ordentliche Hauptversammlung abgehalten. Insgesamt waren 87,51 Prozent des Grundkapitals bei der virtuellen Versammlung vertreten. Es standen 14 Punkte auf der Tagesordnung der Hauptversammlung. Die Aktionärinnen und Aktionäre stimmten allen Beschlussvorschlägen der Verwaltung zu den zur Abstimmung stehenden Tagesordnungspu...
BioNTech SE Shareholders Approve All Agenda Items at the Annual Genera...
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024 MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was represented at the virtual assembly. There were 14 items on the agenda of the AGM. All resolutions proposed on the agenda items put to the vote at today’s AGM were approved by a large majority of the shareholders. “The past few years marked a leap in competence for BioNTech,” said Helmut Jeggle, Chair...
EQS-News: Convocation of the Annual General Meeting
EQS-News: ams-OSRAM AG / Key word(s): AGM/EGM Convocation of the Annual General Meeting 17.05.2024 / 14:41 CET/CEST The issuer is solely responsible for the content of this announcement. ams-OSRAM AG Premstätten, FN 34109 k ISIN AT0000A18XM4 ("Company") Convocation of the Annual General Meeting We hereby invite our shareholders to attend the Annual General Meeting of ams-OSRAM AG on Friday, June 14, 2024, at 10:00 a.m, on the Company’s premises in 8141 Premstätten, Tobelbader Straße 30. I. Agenda Presentation of the annual financial statements includ...
EQS-News: ams-OSRAM AG: Einberufung der ordentlichen Hauptversammlung ...
EQS-News: ams-OSRAM AG / Schlagwort(e): Hauptversammlung ams-OSRAM AG: Einberufung der ordentlichen Hauptversammlung 2024 17.05.2024 / 14:41 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. ams-OSRAM AG Premstätten, FN 34109 k ISIN AT0000A18XM4 (“Gesellschaft”) Einberufung der ordentlichen Hauptversammlung Wir laden hiermit unsere Aktionärinnen und Aktionäre ein zur ordentlichen Hauptversammlung der ams-OSRAM AG am Freitag, den 14. Juni 2024, um 10:00 Uhr, in 8141 Premstätten, Tobelbader Straße 30, in den Räumen der Ge...
- Carole Braudeau
- Carole Braudeau
- Pierre FerraguÊ
Infineon: Microcontroller share gains help offset the cyclical slowdow...
Infineon’s auto MCU revenues have nearly tripled in the last four years, with market share increasing from 16% to 29%. The company has good visibility on further growth, and we expect this, along with growth in xEVs, to offset the cyclical slowdown this year and contribute to double-digit growth beyond. Infineon is one of our top picks this year. The largest round of downward revisions is behind us, and the stock is attractively valued, ahead of another leg of strong secular growth beyond this y...
EQS-News: Elmos: Hauptversammlung beschließt Dividende von 0,85 Euro j...
EQS-News: Elmos Semiconductor SE / Schlagwort(e): Hauptversammlung/Dividende Elmos: Hauptversammlung beschließt Dividende von 0,85 Euro je Aktie 15.05.2024 / 15:51 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Große Mehrheit für alle Tagesordnungspunkte Dortmund, 15. Mai 2024: Die Elmos Semiconductor SE (FSE: ELG) hat heute ihre diesjährige ordentliche Hauptversammlung virtuell abgehalten. Insgesamt waren über 85% des stimmberechtigten Grundkapitals vertreten. Alle Tagesordnungspunkte wurden mit großer Mehrheit angenommen. Die Haup...
EQS-News: Elmos: Annual General Meeting approves dividend of 0.85 Euro...
EQS-News: Elmos Semiconductor SE / Key word(s): AGM/EGM/Dividend Elmos: Annual General Meeting approves dividend of 0.85 Euro per share 15.05.2024 / 15:51 CET/CEST The issuer is solely responsible for the content of this announcement. Large majority for all items on the agenda Dortmund, May 15, 2024: Elmos Semiconductor SE (FSE: ELG) held its virtual Annual General Meeting today. In total, over 85% of the share capital with voting rights was represented. All agenda items were adopted with a large majority. The Annual General Meeting approved a dividend of 0.85 Euro per s...
ASM announces start of €150 million share buyback program
ASM announces start of €150 million share buyback program Almere, The Netherlands May 14, 2024, 6:00 p.m. CET ASM International N.V. (Euronext Amsterdam: ASM) today announces that it will commence a share buyback program of ASM’s common shares of €150 million. This program follows on ASM's announcement on February 27, 2024, that the Management Board authorized a share buyback program for up to €150 million. The program commences on May 15, 2024, and is to end as soon as the aggregate purchase price of the common shares acquired by ASM has reached €150 million, but ultimately on ...
Aixtron AG: 1 director
A director at Aixtron AG bought 4,000 shares at 22.000EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
- Carole Braudeau
- Stephane Beyazian
- Stephane Beyazian
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.